Amorphosynthesis
Amorphosynthesis is a neurological disorder characterized by a loss of the ability to perceive objects or spatial relationships in certain areas of the visual field. It is often associated with brain damage, particularly to the right parietal lobe.
Symptoms[edit]
The primary symptom of amorphosynthesis is a lack of awareness or attention to one side of the visual field, typically the left side. This can manifest in a variety of ways, such as neglecting to eat food on one side of a plate, ignoring objects or people on one side, or even neglecting to dress or groom one side of the body.
Causes[edit]
Amorphosynthesis is typically caused by damage to the right parietal lobe of the brain. This can occur as a result of a stroke, brain tumor, traumatic brain injury, or other neurological conditions.
Diagnosis[edit]
Diagnosis of amorphosynthesis is typically made through a combination of neurological examination, neuropsychological testing, and brain imaging techniques such as MRI or CT scan.
Treatment[edit]
Treatment for amorphosynthesis is typically focused on managing the symptoms and improving the patient's quality of life. This can include occupational therapy to help the patient learn to compensate for their visual neglect, as well as cognitive rehabilitation to improve attention and awareness.
Prognosis[edit]
The prognosis for amorphosynthesis varies widely depending on the severity of the condition and the underlying cause. Some patients may experience a significant improvement in symptoms with treatment, while others may continue to experience difficulties with visual perception.
See also[edit]
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
